Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

7 Oct 2022 16:28

RNS Number : 2322C
Maven Income & Growth VCT PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC

Offers for Subscription

7 October 2022

 

The Board of Directors of Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (together the "Companies" and each a "Company") are pleased to announce that they have published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription for new Ordinary Shares of 10p each in each of the Companies to raise, in aggregate, up to £40 million, including over-allotment facilities of up to, in aggregate, £10 million (before issue costs) (the "Offers" and each an "Offer").

The Companies have also published a joint Circular (the "Circular") seeking the approval of their respective shareholders for the allotment and disapplication authorities in connection with the Offers and each Company giving notice of a General Meeting to be held on 9 November 2022 (the "General Meeting").

The Offers will open on 7 October 2022 and the deadline for receipt of applications is 12.00 noon on 4 April 2023 in relation to the tax year 2022/23 and 12.00 noon on 26 May 2023 in relation to the tax year 2023/24. The Offers will close on 31 May 2023 unless the relevant Offer is fully subscribed by an earlier date or previously extended by the relevant Board to no later than 6 October 2023

Each Offer is conditional on the passing of certain resolutions at the relevant General Meeting.

Pursuant to individual offer agreements dated 7 October 2022 relating to each Offer between, among others, each relevant Company and Maven Capital Partners LLP ("Maven"), Maven, as the administrator of each Offer, will receive an offer administration fee of 2.5% of the application amount in relation to each accepted application, with reductions to the offer administration fee applying for applications that benefit from an Early Investment Incentive discount, or as may otherwise be waived by Maven. Maven, as the investment manager of each Company, is a related party of each Company under the Listing Rules, and the payment of such a fee by the Company to Maven is a transaction to which Listing Rule 11.1.10R applies.

To obtain a copy of the Securities Note, private investors and financial advisers should call Maven on 0141 306 7400. A downloadable version of the Securities Note will shortly be available from the Maven website: www.mavencp.com/vctoffer.

Copies of the Prospectus and Circular are available, free of charge, from Maven at Kintyre House, 205 West George Street, Glasgow G2 2LW.

Copies of the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for viewing online at the following website address: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Any enquiries in respect of the Offers should be directed to:

Maven Capital Partners UK LLPTelephone: 0141 306 7400

E-mail: enquiries@mavencp.com

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

Notes

 

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZZMGGKNVGZZM
Date   Source Headline
30th Mar 200911:05 amRNSAnnual Information Update
30th Mar 200910:15 amRNSAnnual Report and Accounts
10th Mar 200911:20 amRNSAnnual Report and Accounts
6th Mar 200910:26 amRNSC Ordinary shares (on conversion to Ordinary)
2nd Mar 200912:50 pmRNSConversion of Securities
17th Oct 20082:14 pmRNSInterim Management Statement
16th Oct 20082:54 pmRNSResult of EGM
29th Aug 200811:17 amRNSCirc re GM, and issue of inte
16th Jul 20084:34 pmRNSDirectorate Change
15th Jul 20084:17 pmRNSInterim Results
25th Apr 20083:24 pmRNSResult of AGM
17th Apr 200810:23 amRNSInterim Management Statement
7th Mar 20084:01 pmRNSAnnual Information Update
29th Feb 20084:23 pmRNSAnnual Report and Accounts
6th Feb 200811:51 amRNSFinal Results
20th Jul 20075:05 pmRNSInterim Results
12th Jun 20073:14 pmRNSAnnual Information Update
7th Jun 200712:47 pmRNSResult of AGM
7th Feb 20075:13 pmRNSFinal Results
20th Dec 20064:52 pmRNSTotal Voting Rights
8th Nov 20063:08 pmRNSNet Asset Value(s)
14th Jul 20065:11 pmRNSInterim Results
29th Jun 200610:51 amRNSDirector/PDMR Shareholding
29th Jun 200610:50 amRNSDirector/PDMR Shareholding
29th Jun 200610:40 amRNSDirector/PDMR Shareholding
24th May 20069:31 amRNSTransaction in Own Shares
28th Apr 200610:21 amRNSResult of AGM
21st Apr 200611:12 amRNSTransaction in Own Shares
6th Apr 200610:17 amRNSIssue of Equity
4th Apr 200612:10 pmRNSIssue of Equity
3rd Apr 20064:41 pmRNSDoc re.Offer for Subscription
14th Mar 20069:44 amRNSDividend Declaration
21st Feb 20062:48 pmRNSAnnual Information Update
15th Feb 20064:10 pmRNSIssue of Equity
27th Jan 200610:20 amRNSDoc re. Prospectus
24th Jan 200610:36 amRNSAnnual Report and Accounts
30th Dec 20059:57 amRNSFinal Results
22nd Dec 200511:04 amRNSResult of EGM
1st Dec 20055:00 pmRNSStatement re Portfolio Update
29th Nov 20053:10 pmRNSTransaction in Own Shares
18th Nov 20054:57 pmRNSCirc re C Shares
1st Nov 20053:55 pmRNSDirectorate Change
25th Oct 20054:50 pmRNSTransaction in Own Shares
14th Oct 20054:50 pmRNSTransaction in Own Shares
29th Jul 20053:41 pmRNSTransaction in Own Shares
25th Jul 20052:32 pmRNSInterim Results
31st May 20054:21 pmRNSInvestment Activity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.